Chief Executive Officer Of Moderna Makes $7.3M Sale
Stephane Bancel, Chief Executive Officer at Moderna (NASDAQ:MRNA), made a large insider sell on September 30, according to a new SEC filing.
Takeda Says ‘Human Error’ Reason Behind Contaminated Moderna COVID-19 Vaccines
Takeda Pharmaceutical Co Ltd (NYSE: TAK) blamed "human error" as the cause of metal contaminants found in some batches of Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccine.
Why Moderna Is Investing In A New Science Center
Moderna, Inc. (NASDAQ: MRNA), which made a windfall with its COVID-19 vaccine program, is plowing back some of the largesse into R&D.
Moderna To Invest In New Science Center In Cambridge, MA
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it is investing in a new science center, known as the Moderna Science Center, at 325 Binney
NIH-Backed US Study Of Mixed COVID-19 Vaccines Regime To Conclude Soon: CNBC
The National Institutes of Health (NIH) is close to concluding trials evaluating mix n match COVID-19 vaccines regime, reports…
Is Moderna’s COVID-19 Booster Shot Moving Closer To Authorization?
Close on heels of the U.S. Food and Drug Administration issuing restricted authorization for the Pfizer Inc.
Adagio’s COVID-19 Candidate Shows Prolonged Half-Life, Neutralization At Six Months
Adagio Therapeutics Inc (NASDAQ:ADGI) has announced new data from its COVID-19 antibody program. Related Link: Adagio Therapeutics To Expand Late-Stage COVID-19 Antibody…
‘FDA Leans Toward Authorizing Moderna Booster at a Half Dose’ -Bloomberg, From Last Night
https://www.bloomberg.com/news/articles/2021-09-29/fda-leans-toward-authorizing-moderna-booster-at-a-half-dose